OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
-9.4%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$46.9M
AUM Growth
-$11.4M
Cap. Flow
-$3.93M
Cap. Flow %
-8.38%
Top 10 Hldgs %
57.88%
Holding
64
New
2
Increased
18
Reduced
1
Closed
10

Top Buys

1
FBIO icon
Fortress Biotech
FBIO
$535K
2
UTHR icon
United Therapeutics
UTHR
$279K
3
AMRN
Amarin Corp
AMRN
$258K
4
ALKS icon
Alkermes
ALKS
$227K
5
REGN icon
Regeneron Pharmaceuticals
REGN
$60.5K

Top Sells

1
IMMU
Immunomedics Inc
IMMU
$868K
2
SRPT icon
Sarepta Therapeutics
SRPT
$813K
3
BLUE
bluebird bio
BLUE
$743K
4
INSM icon
Insmed
INSM
$690K
5
PCRX icon
Pacira BioSciences
PCRX
$489K

Sector Composition

1 Healthcare 64.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
26
DELISTED
Blueprint Medicines
BPMC
$498K 0.9%
6,780
– –
BOLD
27
DELISTED
Audentes Therapeutics, Inc
BOLD
$487K 0.88%
17,339
– –
GTHX
28
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$475K 0.86%
20,844
– –
GBT
29
DELISTED
Global Blood Therapeutics, Inc.
GBT
$460K 0.83%
9,479
– –
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$453K 0.82%
10,852
– –
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$447K 0.81%
9,770
– –
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.33B
$432K 0.78%
12,005
+24
+0.2% +$864
GWPH
33
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$423K 0.76%
3,674
– –
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
$389K 0.7%
9,725
– –
MGNX icon
35
MacroGenics
MGNX
$118M
$384K 0.69%
30,075
– –
NTLA icon
36
Intellia Therapeutics
NTLA
$1.23B
$380K 0.69%
28,490
– –
TECH icon
37
Bio-Techne
TECH
$8.05B
$303K 0.55%
6,204
– –
IQV icon
38
IQVIA
IQV
$30.4B
$297K 0.54%
1,985
– –
AMGN icon
39
Amgen
AMGN
$153B
$294K 0.53%
1,518
+121
+9% +$23.4K
NBIX icon
40
Neurocrine Biosciences
NBIX
$13.6B
$282K 0.51%
3,127
+115
+4% +$10.4K
CKPT
41
DELISTED
Checkpoint Therapeutics
CKPT
$281K 0.51%
11,276
– –
CRL icon
42
Charles River Laboratories
CRL
$7.76B
$280K 0.51%
2,112
– –
UTHR icon
43
United Therapeutics
UTHR
$17.7B
$279K 0.5%
+3,498
New +$279K
GRFS icon
44
Grifois
GRFS
$6.74B
$264K 0.48%
13,196
– –
BIIB icon
45
Biogen
BIIB
$20.6B
$261K 0.47%
1,123
– –
ICPT
46
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$261K 0.47%
3,926
-1,946
-33% -$129K
GILD icon
47
Gilead Sciences
GILD
$140B
$259K 0.47%
4,082
– –
LGND icon
48
Ligand Pharmaceuticals
LGND
$3.25B
$242K 0.44%
3,892
+508
+15% +$31.6K
NKTR icon
49
Nektar Therapeutics
NKTR
$659M
$235K 0.42%
862
+28
+3% +$7.63K
EXEL icon
50
Exelixis
EXEL
$10B
$232K 0.42%
13,132
+1,692
+15% +$29.9K
1
2
3